Page last updated: 2024-11-08

5-hydroxymethyldeoxycytidylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5-hydroxymethyldeoxycytidylic acid : A 2'-deoxycytidine phosphate compound having the phosphate group at the 5'-position and a hydroxymethyl substituent at the 5-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID440189
CHEBI ID16952
SCHEMBL ID1331043
MeSH IDM0212203

Synonyms (19)

Synonym
5-hydroxymethyl dcmp
5-hydroxymethylcytosine deoxyribonucleotide
5'-cytidylic acid, 2'-deoxy-5-(hydroxymethyl)-
2(1h)-pyrimidinone, 4-amino-1-(2-deoxy-5-o-phosphono-beta-d-erythro-pentofuranosyl)-5-(hydroxymethyl)-
cytidine, 2'-deoxy-5-(hydroxymethyl)-, 5'-(dihydrogen phosphate)
2'-deoxy-5-hydroxymethylcytidine-5'-phosphate
13009-95-5
5-hydroxymethyldeoxycytidylate
5-hydroxymethyldeoxycytidylic acid
C03997
CHEBI:16952
2'-deoxy-5-(hydroxymethyl)cytidine 5'-(dihydrogen phosphate)
5-hmdcyt
[(2r,3s,5r)-5-[4-amino-5-(hydroxymethyl)-2-oxopyrimidin-1-yl]-3-hydroxyoxolan-2-yl]methyl dihydrogen phosphate
SCHEMBL1331043
5-hydroxymethyldeoxy-cytidine monophosphate
DTXSID40156333
Q27102149
((2r,3s,5r)-5-(4-amino-5-(hydroxymethyl)-2-oxopyrimidin-1(2h)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
2'-deoxycytidine phosphate
pyrimidine 2'-deoxyribonucleoside 5'-monophosphate
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (33.33)18.7374
1990's2 (33.33)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.47

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.47 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.42 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.47)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]